Dr Swen Hoelder’s team designs and then synthesises molecules that could be used as cancer drugs.
Dr Swen Hoelder is a key member of the Cancer Research UK Cancer Therapeutics Unit and applies his medicinal chemistry experience to discover and develop new cancer drugs. He has worked in both academia and industry, and has led teams to discover drug screening libraries and pre-clinical candidates.